CL vs ERNA · P/E 34, rev $20.38B vs P/E 0.0, rev $582.0K
Colgate-Palmolive Company (CL) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CL currently screens at market cap $70.88B and trailing P/E 34.3. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CL and ERNA stock pages for the full models.
Not investment advice.